Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | RMC-4998 |
Trade Name | |
Synonyms | RMC4998|RMC 4998 |
Drug Descriptions |
RMC-4998 is a small molecule that selectively inhibits active KRAS G12C by forming a tri-complex with KRAS G12C and cyclophilin A, potentially resulting in decreased RAS signaling and tumor cell proliferation, and reduced tumor growth (PMID: 37590355). |
DrugClasses | KRAS G12C inhibitor 34 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
RMC-4550 + RMC-4998 + unspecified CTLA4 antibody | RMC-4550 RMC-4998 unspecified CTLA4 antibody | 0 | 0 |
RMC-4550 + RMC-4998 + unspecified PD-1 antibody | RMC-4550 RMC-4998 unspecified PD-1 antibody | 0 | 0 |
RMC-4998 | RMC-4998 | 0 | 0 |
RMC-4998 + RMC-7977 | RMC-4998 RMC-7977 | 0 | 0 |